Surgalign Holdings, Inc. Common Stock
SRGA
SRGA was delisted on the 30th of June, 2023.
89 hedge funds and large institutions have $80.2M invested in Surgalign Holdings, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 33 reducing their positions, and 36 closing their positions.
28% more call options, than puts
Call options by funds: $251K | Put options by funds: $196K
15% less funds holding
Funds holding: 105 → 89 (-16)
36% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 33
39% less capital invested
Capital invested by funds: $132M → $80.2M (-$51.4M)
44% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 36
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$5.33M |
| 2 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
+$3.75M |
| 3 |
Mitsubishi UFJ Asset Management
Tokyo,
Japan
|
+$3.42M |
| 4 |
Morgan Stanley
New York
|
+$3.22M |
| 5 |
ACM
Altium Capital Management
New York
|
+$2.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$8.51M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$5.74M |
| 3 |
DI
DFPG Investments
Sandy,
Utah
|
-$4.99M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$3.2M |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$2M |
SRGA Hedge Fund Activity: Q2 2021 in Review
89 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q2 2021, worth a combined $80.2M — down 39% from $132M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of SRGA and 20 opened new positions — a net loss of 16 holders — while 33 trimmed existing stakes and 21 added.
The largest buyer was State Street, adding an estimated $5.33M. The largest seller was BlackRock, cutting an estimated $8.51M.
- 89 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q2 2021, down from 105 in Q1 2021.
- Funds reported $80.2M of Surgalign Holdings, Inc. Common Stock stock for Q2 2021, down 39% quarter-over-quarter.
- 20 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q2 2021 and 36 closed out, a net change of -16 holders.
- The largest Surgalign Holdings, Inc. Common Stock buyer in Q2 2021 was State Street, an estimated $5.33M added.
- The largest Surgalign Holdings, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $8.51M sold.
Based on aggregated 13F filings for Q2 2021.